Ruzan Avetisyan

699 total citations
12 papers, 434 citations indexed

About

Ruzan Avetisyan is a scholar working on Pediatrics, Perinatology and Child Health, Physiology and Psychiatry and Mental health. According to data from OpenAlex, Ruzan Avetisyan has authored 12 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pediatrics, Perinatology and Child Health, 3 papers in Physiology and 3 papers in Psychiatry and Mental health. Recurrent topics in Ruzan Avetisyan's work include Epilepsy research and treatment (3 papers), Pharmacological Effects and Toxicity Studies (3 papers) and Food Allergy and Anaphylaxis Research (2 papers). Ruzan Avetisyan is often cited by papers focused on Epilepsy research and treatment (3 papers), Pharmacological Effects and Toxicity Studies (3 papers) and Food Allergy and Anaphylaxis Research (2 papers). Ruzan Avetisyan collaborates with scholars based in United States, United Kingdom and France. Ruzan Avetisyan's co-authors include Olivier Lidove, Bernd‐Jan Sanson, Margaret M. McGovern, Dan R. Berlowitz, Lewis E. Kazis, Mary Jo Pugh, Gabriel D. Shapiro, Amresh Hanchate, Jaya K. Rao and Philip Rotella and has published in prestigious journals such as BMC Health Services Research, Value in Health and Orphanet Journal of Rare Diseases.

In The Last Decade

Ruzan Avetisyan

12 papers receiving 427 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruzan Avetisyan United States 11 105 100 97 76 54 12 434
K Weiss United States 9 60 0.6× 67 0.7× 54 0.6× 84 1.1× 34 0.6× 14 661
J.J. Kerssens United Kingdom 12 94 0.9× 27 0.3× 50 0.5× 80 1.1× 91 1.7× 32 586
Lonneke Timmers Netherlands 13 146 1.4× 27 0.3× 106 1.1× 80 1.1× 30 0.6× 29 621
Mei‐Ju Ko Taiwan 14 57 0.5× 74 0.7× 19 0.2× 37 0.5× 43 0.8× 34 760
Heather Morris United States 14 28 0.3× 47 0.5× 39 0.4× 96 1.3× 33 0.6× 48 467
Michael Grabner United States 17 40 0.4× 38 0.4× 41 0.4× 68 0.9× 140 2.6× 80 811
Mary Shaw United States 7 104 1.0× 38 0.4× 82 0.8× 65 0.9× 30 0.6× 12 616
Marci Clark United States 11 57 0.5× 55 0.6× 36 0.4× 54 0.7× 14 0.3× 21 495
Jessamyn Conell‐Price United States 9 43 0.4× 53 0.5× 20 0.2× 97 1.3× 37 0.7× 13 457
Wendy Camelo Castillo United States 8 53 0.5× 31 0.3× 36 0.4× 41 0.5× 35 0.6× 21 411

Countries citing papers authored by Ruzan Avetisyan

Since Specialization
Citations

This map shows the geographic impact of Ruzan Avetisyan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruzan Avetisyan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruzan Avetisyan more than expected).

Fields of papers citing papers by Ruzan Avetisyan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruzan Avetisyan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruzan Avetisyan. The network helps show where Ruzan Avetisyan may publish in the future.

Co-authorship network of co-authors of Ruzan Avetisyan

This figure shows the co-authorship network connecting the top 25 collaborators of Ruzan Avetisyan. A scholar is included among the top collaborators of Ruzan Avetisyan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruzan Avetisyan. Ruzan Avetisyan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
McGovern, Margaret M., Ruzan Avetisyan, Bernd‐Jan Sanson, & Olivier Lidove. (2017). Disease manifestations and burden of illness in patients with acid sphingomyelinase deficiency (ASMD). Orphanet Journal of Rare Diseases. 12(1). 41–41. 98 indexed citations
2.
3.
Avetisyan, Ruzan, Howard Cabral, Georgia Montouris, et al.. (2013). Evaluating racial/ethnic variations in outpatient epilepsy care. Epilepsy & Behavior. 27(1). 95–101. 14 indexed citations
4.
Jones, Natalie, et al.. (2012). A systematic review of validated methods for identifying acute respiratory failure using administrative and claims data. Pharmacoepidemiology and Drug Safety. 21(S1). 261–264. 14 indexed citations
5.
Bash, Lori D., Jessica Buono, Glenn Davies, et al.. (2012). Systematic Review and Meta-analysis of the Efficacy of Cardioversion by Vernakalant and Comparators in Patients with Atrial Fibrillation. Cardiovascular Drugs and Therapy. 26(2). 167–179. 43 indexed citations
6.
Kachroo, Sumesh, Natalie Jones, Sheila Crean, et al.. (2012). A systematic review of validated methods for identifying anaphylaxis, including anaphylactic shock and angioneurotic edema, using administrative and claims data. Pharmacoepidemiology and Drug Safety. 21(S1). 240–247. 27 indexed citations
7.
Kachroo, Sumesh, Natalie Jones, Sheila Crean, et al.. (2012). A systematic review of validated methods for identifying hypersensitivity reactions other than anaphylaxis (fever, rash, and lymphadenopathy), using administrative and claims data. Pharmacoepidemiology and Drug Safety. 21(S1). 248–255. 13 indexed citations
8.
Jones, Natalie, G Schneider, Sumesh Kachroo, et al.. (2012). A systematic review of validated methods for identifying pulmonary fibrosis and interstitial lung disease using administrative and claims data. Pharmacoepidemiology and Drug Safety. 21(S1). 256–260. 21 indexed citations
9.
Kachroo, Sumesh, Natalie Jones, Sheila Crean, et al.. (2012). A systematic review of validated methods for identifying erythema multiforme major/minor/not otherwise specified, Stevens–Johnson Syndrome, or toxic epidermal necrolysis using administrative and claims data. Pharmacoepidemiology and Drug Safety. 21(S1). 236–239. 16 indexed citations
10.
Brooks, Daniel R., Ruzan Avetisyan, Amresh Hanchate, et al.. (2011). Validation of self-reported epilepsy for purposes of community surveillance. Epilepsy & Behavior. 23(1). 57–63. 47 indexed citations
11.
Pugh, Mary Jo, Dan R. Berlowitz, Jaya K. Rao, et al.. (2011). The quality of care for adults with epilepsy: an initial glimpse using the QUIET measure. BMC Health Services Research. 11(1). 1–1. 110 indexed citations
12.
Bokhour, Barbara G., Mary Jo Pugh, Jaya K. Rao, et al.. (2008). Improving Methods for Measuring Quality of Care. Medical Care Research and Review. 66(2). 147–166. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by K Weiss Breakdown of academic impact, for papers by J.J. Kerssens Breakdown of academic impact, for papers by Lonneke Timmers Breakdown of academic impact, for papers by Mei‐Ju Ko Breakdown of academic impact, for papers by Heather Morris Breakdown of academic impact, for papers by Michael Grabner Breakdown of academic impact, for papers by Mary Shaw Breakdown of academic impact, for papers by Marci Clark Breakdown of academic impact, for papers by Jessamyn Conell‐Price Breakdown of academic impact, for papers by Wendy Camelo Castillo
Rankless by CCL
2026